Učitavanje...
The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...
Spremljeno u:
| Izdano u: | Cancers Head Neck |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460729/ https://ncbi.nlm.nih.gov/pubmed/31093338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41199-016-0009-6 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|